Healthcare / Medical Care FacilitiesBSE
$151.30
+8.70 (+6.10%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $393.4M · quality 70.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$12.4B
P/E
29.4x
↑EV/EBITDA
14.7x
↑ROE
15.7%
↑Gross Margin
63.1%
↑Debt/Equity
0.34
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+9.5%
FCF CAGR
-11.3%
FCF margin
8.3%
FCF / Net income
0.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.73B · net income $422.2M · FCF $393.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.73B | $4.73B | $4.07B | $4.00B | $3.60B |
| Net Income | $422.2M | $422.2M | $499.2M | $477.7M | $390.1M |
| EBITDA | $901.3M | $901.3M | $918.5M | $925.2M | $793.2M |
| EPS | 5.15 | 5.15 | 6.08 | 5.96 | 4.75 |
| Gross Margin | 63.1% | 63.1% | 62.7% | 63.1% | 62.9% |
| Operating Margin | 12.1% | 12.1% | 15.8% | 18.0% | 16.5% |
| Net Margin | 8.9% | 8.9% | 12.3% | 12.0% | 10.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.34 | 0.34 | 0.14 | 0.14 | 0.50 |
| Current Ratio | 1.12 | 1.12 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $393.4M | $393.4M | $174.7M | $494.3M | $564.1M |
| Returns | |||||
| ROE | 15.7% | 15.7% | 20.1% | 21.9% | 23.6% |
| Valuation | |||||
| P/E | 29.38 | 29.38 | 27.70 | 30.65 | — |
| EV/EBITDA | 14.73 | 14.73 | 15.42 | 16.12 | — |
| P/B | 4.60 | 4.60 | 5.58 | 6.70 | — |
| Growth & Yield | |||||
| Revenue Growth | 16.1% | 16.1% | 1.9% | 10.9% | — |
| EPS Growth | -15.3% | -15.3% | 2.0% | 25.4% | — |
| Dividend Yield | 2.1% | 2.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
37.6%
EPS terminal req.
$13.43
Spread vs growth
-52.9%
5Y implied EPS CAGR
25.8%
EPS terminal req.
$16.24
Spread vs growth
-41.1%
10Y implied EPS CAGR
17.6%
EPS terminal req.
$26.16
Spread vs growth
-32.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.9%
Start / end P/E
25.2x → 29.4x
EPS bridge
6.08 → 5.15
Residual
-2.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.